Home Cart Sign in  
Chemical Structure| 1431-40-9 Chemical Structure| 1431-40-9

Structure of 1431-40-9

Chemical Structure| 1431-40-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 1431-40-9 ]

CAS No. :1431-40-9
Formula : C5H9N5S
M.W : 171.22
SMILES Code : NC1=NC(SC)=NC(N)=C1N
MDL No. :MFCD00023239
InChI Key :CTHYWCCCVXWRCA-UHFFFAOYSA-N
Pubchem ID :229266

Safety of [ 1431-40-9 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 1431-40-9 ] Show Less

Physicochemical Properties

Num. heavy atoms 11
Num. arom. heavy atoms 6
Fraction Csp3 0.2
Num. rotatable bonds 1
Num. H-bond acceptors 2.0
Num. H-bond donors 3.0
Molar Refractivity 46.97
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

129.14 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.94
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

-0.33
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

-0.03
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.78
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.63
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

-0.17

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.03
Solubility 15.9 mg/ml ; 0.093 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-1.92
Solubility 2.06 mg/ml ; 0.012 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.07
Solubility 14.6 mg/ml ; 0.0853 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-7.58 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.23

Application In Synthesis of [ 1431-40-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1431-40-9 ]

[ 1431-40-9 ] Synthesis Path-Downstream   1~34

  • 1
  • [ 64-18-6 ]
  • [ 1431-40-9 ]
  • <i>N</i>-(4,6-diamino-2-methylsulfanyl-pyrimidin-5-yl)-formamide [ No CAS ]
  • 2
  • [ 4230-33-5 ]
  • [ 1431-40-9 ]
  • [ 5221-17-0 ]
  • [ 94543-82-5 ]
  • 3
  • [ 1431-40-9 ]
  • [ 5221-17-0 ]
  • [ 150-13-0 ]
  • [ 93898-79-4 ]
  • 4
  • [ 1431-40-9 ]
  • [ 69316-68-3 ]
  • [ 98197-66-1 ]
  • 5
  • [ 1431-40-9 ]
  • [ 431-03-8 ]
  • [ 19152-98-8 ]
  • 6
  • [ 1431-40-9 ]
  • [ 95-92-1 ]
  • 4-amino-2-methylsulfanyl-5,8-dihydro-pteridine-6,7-dione [ No CAS ]
  • 7
  • [ 1431-40-9 ]
  • [ 134-81-6 ]
  • [ 15263-43-1 ]
  • 8
  • [ 1431-40-9 ]
  • 5-chloro-[1,2,5]thiadiazolo[3,4-<i>d</i>]pyrimidin-7-ylamine [ No CAS ]
  • 9
  • [ 1431-40-9 ]
  • [ 87866-19-1 ]
  • 11
  • [ 1431-40-9 ]
  • [ 5336-08-3 ]
  • [ 102879-86-7 ]
  • 12
  • [ 1431-40-9 ]
  • [ 90-80-2 ]
  • [ 1195634-63-9 ]
  • 13
  • [ 1431-40-9 ]
  • [ 6306-87-2 ]
  • 14
  • [ 1431-40-9 ]
  • [ 28767-74-0 ]
  • [ 130790-19-1 ]
  • 15
  • [ 1431-40-9 ]
  • [ 622-12-8 ]
  • [ 130695-40-8 ]
  • 16
  • [ 1431-40-9 ]
  • [ 622-12-8 ]
  • [ 130592-61-9 ]
  • 19
  • [ 56-23-5 ]
  • [ 7791-25-5 ]
  • [ 1431-40-9 ]
  • 5-chloro-[1,2,5]thiadiazolo[3,4-<i>d</i>]pyrimidin-7-ylamine [ No CAS ]
  • 20
  • [ 56-23-5 ]
  • [ 1431-40-9 ]
  • [ 7782-50-5 ]
  • 5-chloro-[1,2,5]thiadiazolo[3,4-<i>d</i>]pyrimidin-7-ylamine [ No CAS ]
YieldReaction ConditionsOperation in experiment
EXAMPLE 3 4,5,6-Triamino-2-(methylthio)pyrimidine STR13 Sodium hydrosulfite (sodium dithionite, 78.3 g., 0.45 mole) is added in one portion to a stirred suspension of 4,6-diamino-2-(methylthio)-5-nitrosopyrimidine (27.8 g., 0.15 mole) in 300 ml. 1 N sodium hydroxide. Within a 15-20 minute period, the temperature of the mixture increases to 60 with concommitant foaming. The mixture is stirred for a 16 hr. period, insolubles collected and washed well with water, air-dried, and crystallized from acetonitrile to yield 19.73 g. (76.8%) of 4,5,6-triamino-2-(methylthio)pyrimidine as yellow crystals, m.p. 180-182.
The resulting solution was warmed to a temperature ranging from 60 to 65C and thereto was added Na2S2O4 until color of the solution became disappeared. The resultant clear solution was adjusted to pH 9 and cooled to produce precipitates, which were filtered and dried to obtain 98.4g of the title compound. m.p.: 208C NMR(delta, DMSO-d6): 5.68(s, 4H), 3.58(s, 2H), 2.31(s, 3H)
Preparation Example 21 : Synthesis of 1,4,5,6-tetraamino pyrimidine-2-thione To a solution of 17.1g of 4,5,6-triamino-2-methylthio pyrimidine, which was obtained in Preparation Example 1 above, dissolved in 100 ml of dichloromethane was added dropwise a solution of 43g of hydroxylamine-0-mesitylene sulfonate dissolved in 50 ml of dichloromethane at 0C.
  • 22
  • [ 1431-40-9 ]
  • [ 130695-41-9 ]
  • 23
  • [ 1431-40-9 ]
  • [ 130592-62-0 ]
  • 26
  • [ 213124-94-8 ]
  • [ 1431-40-9 ]
  • [ 213248-30-7 ]
  • 27
  • [ 73568-25-9 ]
  • [ 1431-40-9 ]
  • [ 1214720-43-0 ]
  • 28
  • [ 1431-40-9 ]
  • [ 501676-50-2 ]
  • [ 1402415-38-6 ]
  • 29
  • [ 1431-40-9 ]
  • [ 111038-89-2 ]
  • [ 1402415-39-7 ]
  • 30
  • [ 1431-40-9 ]
  • [ 849045-70-1 ]
  • [ 1402415-43-3 ]
  • 31
  • [ 1431-40-9 ]
  • [ 110334-09-3 ]
  • [ 1402415-41-1 ]
  • 32
  • [ 1005-38-5 ]
  • [ 1431-40-9 ]
  • 33
  • [ 1431-40-9 ]
  • 2-(6-amino-2-(methylthio)-9H-purin-8-ylthio)-N-(3,4-dimethoxyphenyl)acetamide [ No CAS ]
  • 34
  • [ 75-15-0 ]
  • [ 1431-40-9 ]
  • 6-amino-2-(methylthio)-7H-purine-8(9H)-thione [ No CAS ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 1431-40-9 ]

Sulfides

Chemical Structure| 73000-30-3

A143923 [73000-30-3]

2-(Ethylthio)pyrimidine-4,5,6-triamine

Similarity: 0.92

Chemical Structure| 1005-39-6

A183548 [1005-39-6]

2-(Methylthio)pyrimidine-4,6-diamine

Similarity: 0.84

Chemical Structure| 2183-66-6

A122372 [2183-66-6]

2-(Methylthio)pyrimidin-4-amine

Similarity: 0.82

Related Parent Nucleus of
[ 1431-40-9 ]

Pyrimidines

Chemical Structure| 73000-30-3

A143923 [73000-30-3]

2-(Ethylthio)pyrimidine-4,5,6-triamine

Similarity: 0.92

Chemical Structure| 73000-30-3

A143923 [73000-30-3]

2-(Ethylthio)pyrimidine-4,5,6-triamine

Similarity: 0.92

Chemical Structure| 1005-39-6

A183548 [1005-39-6]

2-(Methylthio)pyrimidine-4,6-diamine

Similarity: 0.84

Chemical Structure| 2183-66-6

A122372 [2183-66-6]

2-(Methylthio)pyrimidin-4-amine

Similarity: 0.82